Additionally, another meta-analysis comprising 1913 CRC patients and 2851 healthy individuals has shown that SEPT9 and SDC2 methylation analysis in plasma or fecal samples have similar sensitivity and specificity in the diagnosis of CRC, thus suggesting that further studies on epigenetic markers are indeed required [36]. The gene discussed is SDC2; the disease is colorectal carcinoma.